Poor aqueous solubility and physicochemical instability
Research gap analysis derived from 4 chemistry papers in our local library.
The gap
Poor aqueous solubility and physicochemical instability limit the bioavailability and therapeutic efficacy of many drug candidates. There is a need for multifunctional nanocarriers to address these challenges.
Evidence profile
Sourced from the stated research gap and future-work section of the source papers, classified as general, spanning 4 journals. Those papers have been cited 2 times in total.
Research trend
Established — well-defined area with open sub-problems.
Supporting evidence — 4 representative gaps
- A REVIEW ON NANOTECHNOLOGY BASED DRUG DELIVERY SYSTEM (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi
The development of safe and effective nanotechnology-based drug delivery systems is a significant challenge. The long-term exposure to nanomaterials is a significant issue that needs extensive research. The surface characteristics and chemistry of nanoparticles can affect immunity and cellular damage.
generalstated research gapevidence 5/5Keywords: development safe effective nanotechnology-based drug delivery systems significant - Bridging solubility, stability, and translation: advances in carbon nanotube–based drug delivery systems (2026) · DARU Journal of Pharmaceutical Sciences · doi
Poor aqueous solubility and physicochemical instability limit the bioavailability and therapeutic efficacy of many drug candidates. There is a need for multifunctional nanocarriers to address these challenges.
generalstated research gapevidence 5/5Keywords: poor aqueous solubility physicochemical instability limit bioavailability therapeutic - Nanotechnology-Driven Approaches to Bioactive Compound Delivery: Mechanisms, Platforms, and Translational Potential (2026) · BioNanoScience · doi
The clinical and nutritional efficacy of bioactive compounds is frequently constrained by poor aqueous solubility, chemical instability, and low oral bioavailability. There is a need for the development of nanoscale delivery systems that can enhance the stability, efficacy, and targeted delivery of bioactives.
generalstated research gapevidence 5/5Keywords: clinical nutritional efficacy bioactive compounds frequently constrained poor - A rationally designed polypeptide-based hybrid platform for targeted intranasal brain drug delivery (2026) · Biomaterials · cited 2× · doi
Further evaluation of the potential toxicity of the nanocarrier system. Detailed analysis of the pharmacokinetics and pharmacodynamics of the delivered therapeutics. Exploration of the use of the platform for the delivery of a wide range of therapeutics.
generalfuture-work sectionevidence 5/5Keywords: further evaluation potential toxicity nanocarrier system detailed analysis
Questions about this gap
Explore this gap further
Run this gap as a query across open scholarly engines for the latest related literature.
Working on this gap? Review it with us.
Science AI Journal reviews manuscripts in one pass with 8 specialised AI agents calibrated on 69,000+ real peer reviews.
Tools for your next paper
Related gaps in Chemistry
- In vivo evaluation of the nanocompositeIn vivo evaluation of the nanocomposite. Investigation of the long-term effects of the nanocomposite. Exploration of the use of green synthe…
- Information on the abundance of microplastics in greenInformation on the abundance of microplastics in green mussels and waters of Mangkang Beach. The study aims to fill this gap by providing ne…
- The development of novel therapeutic agentsThe development of novel therapeutic agents for the treatment of antimicrobial-resistant infections. The lack of dual-acting molecules that …
- Electrocatalyst degradation is a major limitationElectrocatalyst degradation is a major limitation in sustainable energy conversion, yet nanoscale insight into the interfacial processes gov…